Plus Therapeutics (PSTV) Short Interest Ratio & Short Volume $0.60 +0.11 (+21.73%) Closing price 04:00 PM EasternExtended Trading$0.58 -0.02 (-2.93%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Plus Therapeutics Short Interest DataPlus Therapeutics (PSTV) has a short interest of 5.74 million shares, representing 11.70% of the float (the number of shares available for trading by the public). This marks a 390.60% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 22.57 million shares to cover all short positions.Current Short Interest5,740,000 sharesPrevious Short Interest1,170,000 sharesChange Vs. Previous Month+390.60%Dollar Volume Sold Short$2.00 millionShort Interest Ratio0.2 Days to CoverLast Record DateJune 30, 2025Outstanding Shares60,490,000 sharesShort Percent of Float11.70%Today's Trading Volume88,309,737 sharesAverage Trading Volume22,571,846 sharesToday's Volume Vs. Average391% Short Selling Plus Therapeutics? Sign up to receive the latest short interest report for Plus Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPSTV Short Interest Over TimePSTV Days to Cover Over TimePSTV Percentage of Float Shorted Over Time Plus Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/20255,740,000 shares $2.00 million +390.6%11.7%0.2 $0.35 6/15/20251,170,000 shares $367.38 thousand +128.0%7.2%0.1 $0.31 5/31/2025513,100 shares $145.16 thousand -85.3%9.2%0 $0.28 5/15/20253,490,000 shares $1.77 million +67.8%22.5%0.2 $0.51 4/30/20252,080,000 shares $1.50 million +84.1%12.6%0.1 $0.72 4/15/20251,130,000 shares $735.63 thousand -9.6%6.8%0.1 $0.65 3/31/20251,250,000 shares $1.19 million +34.5%7.5%0.1 $0.95 3/15/2025929,600 shares $631.01 thousand +562.1%8.1%0.1 $0.68 2/28/2025140,400 shares $101.79 thousand +134.4%2.4%0 $0.73 2/15/202559,900 shares $74.28 thousand -32.2%1.0%1.1 $1.24 Get the Latest News and Ratings for PSTV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Plus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202588,400 shares $108.73 thousand -12.8%1.5%1.2 $1.23 1/15/2025101,400 shares $121.68 thousand -10.6%1.8%1.4 $1.20 12/31/2024113,400 shares $130.41 thousand +20.6%2.0%1.5 $1.15 12/15/202494,000 shares $119.38 thousand -17.5%1.6%1 $1.27 11/30/2024114,000 shares $145.92 thousand +9.6%2.0%1.3 $1.28 11/15/2024104,000 shares $121.68 thousand +98.9%1.8%1.3 $1.17 10/31/202452,300 shares $68.77 thousand -3.2%0.9%0.7 $1.32 10/15/202454,000 shares $76.14 thousand -43.4%0.9%0.9 $1.41 9/30/202495,400 shares $139.28 thousand +81.0%1.7%1.3 $1.46 9/15/202452,700 shares $78.00 thousand +51.0%0.9%1 $1.48 8/31/202434,900 shares $49.91 thousand -58.2%0.6%0.6 $1.43 8/15/202483,500 shares $116.90 thousand -35.3%1.4%1.4 $1.40 7/31/2024129,000 shares $232.20 thousand -39.3%2.3%2.2 $1.80 7/15/2024212,600 shares $389.06 thousand -9.2%3.8%2.4 $1.83 6/30/2024234,100 shares $344.13 thousand +14.0%4.2%3.1 $1.47 6/15/2024205,300 shares $410.60 thousand +19.9%3.7%2.7 $2.00 5/31/2024171,300 shares $378.57 thousand +6.5%3.1%2.4 $2.21 5/15/2024160,800 shares $373.06 thousand +248.8%2.9%2.2 $2.32 4/30/202446,100 shares $80.24 thousand -0.9%1.1%0.7 $1.74 4/15/202446,500 shares $80.91 thousand -0.6%1.1%1.5 $1.74 3/31/202446,800 shares $84.47 thousand +45.3%1.1%1.5 $1.81 3/15/202432,200 shares $55.71 thousand -21.1%0.8%0.9 $1.73 2/29/202440,800 shares $79.15 thousand -12.1%1.0%1.1 $1.94 2/15/202446,400 shares $92.34 thousand +7.2%1.0%1.2 $1.99 1/31/202443,300 shares $87.03 thousand -25.3%1.0%0.6 $2.01 1/15/202458,000 shares $120.06 thousand +21.9%1.3%0.2 $2.07 12/31/202347,600 shares $83.30 thousand -26.3%1.1%0.2 $1.75 12/15/202364,600 shares $123.39 thousand -25.5%1.5%0.2 $1.91 11/30/202386,700 shares $147.39 thousand -59.7%2.0%0.1 $1.70 11/15/2023215,000 shares $406.35 thousand +441.6%4.9%0.3 $1.89BREAKING: The House just passed 3 pro-crypto bills! (Ad)99.8% voted YES on this crypto partnership Kraken—one of the world's biggest crypto exchanges—just picked ONE DeFi protocol to power their new blockchain.Discover our #1 altcoin for the market right now. 10/31/202339,700 shares $48.43 thousand -43.8%0.9%0.1 $1.22 10/15/202370,600 shares $97.43 thousand -27.6%2.5%0.2 $1.38 9/30/202397,500 shares $130.65 thousand -30.6%3.4%0.2 $1.34 9/15/2023140,500 shares $195.30 thousand +347.5%5.0%0.3 $1.39 8/31/202331,400 shares $87.61 thousand -50.4%1.1%0.1 $2.79 8/15/202363,300 shares $153.82 thousand +76.8%2.2%1.5 $2.43 7/31/202335,800 shares $88.07 thousand +35.6%1.4%1 $2.46 7/15/202326,400 shares $54.65 thousand -13.2%1.1%0.8 $2.07 6/30/202330,400 shares $61.41 thousand -24.6%1.2%1 $2.02 6/15/202340,300 shares $122.51 thousand -3.8%1.6%1.5 $3.04 5/31/202341,900 shares $168.44 thousand -14.3%1.7%1.7 $4.02 5/15/202348,900 shares $213.69 thousand +154.7%2.0%1.9 $4.37 4/30/202319,200 shares $74.82 thousand -66.6%0.8%0.8 $3.90 4/15/202357,500 shares $15.94 thousand -76.7%N/A0.2 $0.28 3/31/2023247,100 shares $71.66 thousand -13.8%N/A0.9 $0.29 3/15/2023286,600 shares $80.39 thousand +4.1%N/A0.9 $0.28 2/28/2023275,400 shares $93.69 thousand -31.4%N/A0.8 $0.34 2/15/2023401,600 shares $156.62 thousand -14.9%N/A1.2 $0.39 1/31/2023472,000 shares $204.52 thousand +17.2%N/A1.4 $0.43 1/15/2023402,600 shares $192.52 thousand +39.7%N/A1.2 $0.48 12/30/2022288,200 shares $91.36 thousand -31.9%N/A0.7 $0.32 12/15/2022423,100 shares $132.01 thousand -5.0%N/A0.6 $0.31 11/30/2022445,200 shares $179.28 thousand -17.8%N/A0.5 $0.40 11/15/2022541,500 shares $234.96 thousand -11.4%N/A0.4 $0.43 10/31/2022610,900 shares $287.12 thousand -50.3%N/A0.1 $0.47 10/15/20221,230,000 shares $642.06 thousand +388.9%N/A0.3 $0.52 9/30/2022251,600 shares $111.96 thousand +74.0%N/A0.1 $0.45 9/15/2022144,600 shares $89.57 thousand -73.5%N/A0 $0.62 8/31/2022545,600 shares $457.98 thousand +865.7%N/A0.1 $0.84 8/15/202256,500 shares $32.04 thousand +289.7%N/A0 $0.57 7/31/202214,500 shares $7.18 thousand -67.5%N/A0.2 $0.49 7/15/202244,600 shares $22.64 thousand +117.6%0.4%0.4 $0.51 6/30/202220,500 shares $11.07 thousand +57.7%0.2%0.1 $0.54 6/15/202213,000 shares $7.28 thousand +106.4%0.1%0.1 $0.56 5/31/20226,300 shares $3.53 thousand -43.2%N/A0 $0.56 5/15/202211,100 shares $5.38 thousand -77.3%N/A0.1 $0.48 4/30/202248,900 shares $32.76 thousand -49.2%N/A0.2 $0.67 4/15/202296,300 shares $87.54 thousand +154.1%N/A0.3 $0.91 3/31/202237,900 shares $37.90 thousand -58.3%N/A0 $1.00 3/15/202290,900 shares $87.26 thousand -69.7%N/A0 $0.96 2/28/2022300,000 shares $312 thousand +11.4%N/A0.1 $1.04 2/15/2022269,400 shares $280.18 thousand -38.3%1.3%0.1 $1.04 1/31/2022436,400 shares $411.96 thousand +70.2%2.9%0.1 $0.94 1/15/2022256,400 shares $264.09 thousand +594.9%1.7%0.1 $1.03 12/31/202136,900 shares $38.75 thousand -0.3%N/A0 $1.05 12/15/202137,000 shares $44.40 thousand -62.7%0.3%0.1 $1.20 11/30/202199,100 shares $148.65 thousand -13.1%0.7%0.3 $1.50 11/15/2021114,000 shares $191.52 thousand +91.6%0.8%0.1 $1.68 10/29/202159,500 shares $113.05 thousand -47.9%0.4%0 $1.90 10/15/2021114,200 shares $199.85 thousand -28.5%0.8%0.1 $1.75BREAKING: The House just passed 3 pro-crypto bills! (Ad)99.8% voted YES on this crypto partnership Kraken—one of the world's biggest crypto exchanges—just picked ONE DeFi protocol to power their new blockchain.Discover our #1 altcoin for the market right now. 9/30/2021159,600 shares $304.84 thousand -66.0%1.1%0.1 $1.91 9/15/2021469,400 shares $868.39 thousand +121.0%3.1%0.3 $1.85 8/31/2021212,400 shares $414.18 thousand +41.7%1.4%0.2 $1.95 8/13/2021149,900 shares $311.79 thousand -40.8%1.3%0.3 $2.08 7/30/2021253,400 shares $481.46 thousand -14.1%2.1%0.6 $1.90 7/15/2021295,000 shares $660.80 thousand -9.7%2.9%0.3 $2.24 6/30/2021326,700 shares $836.35 thousand -3.9%3.2%0.3 $2.56 6/15/2021340,100 shares $925.07 thousand -65.0%3.7%0.3 $2.72 5/28/2021972,000 shares $2.30 million -28.5%10.7%0.8 $2.37 5/14/20211,360,000 shares $2.77 million +34.7%15.0%1.1 $2.04 4/30/20211,010,000 shares $2.41 million +103.3%11.3%0.6 $2.39 4/15/2021496,700 shares $1.09 million +30.9%5.6%0.5 $2.19 3/31/2021379,600 shares $903.45 thousand +125.3%4.2%0.4 $2.38 3/15/2021168,500 shares $500.45 thousand +12.4%1.9%0.2 $2.97 2/26/2021149,900 shares $449.70 thousand -2.9%1.7%0.2 $3.00 2/12/2021154,300 shares $524.62 thousand +2.7%3.4%0.2 $3.40 1/29/2021150,300 shares $371.24 thousand +440.7%3.3%0.4 $2.47 1/15/202127,800 shares $65.89 thousand -25.1%0.6%0.1 $2.37 12/31/202037,100 shares $77.54 thousand -52.8%0.8%0.1 $2.09 12/15/202078,600 shares $158.77 thousand +104.7%1.8%0.3 $2.02 11/30/202038,400 shares $82.18 thousand -65.5%0.9%0.1 $2.14 11/15/2020111,300 shares $254.88 thousand -29.2%2.5%0.1 $2.29 10/30/2020157,300 shares $353.93 thousand -28.6%3.5%0.2 $2.25 10/15/2020220,400 shares $579.65 thousand -42.1%4.9%0.2 $2.63 9/30/2020380,500 shares $974.08 thousand +29.6%9.1%0.4 $2.56 9/15/2020293,500 shares $889.31 thousand +6.9%7.3%0.3 $3.03 8/31/2020274,500 shares $672.53 thousand -7.6%6.9%0.5 $2.45 8/14/2020297,100 shares $879.42 thousand -15.8%7.5%0.7 $2.96 7/31/2020353,000 shares $857.79 thousand +34.7%8.8%0.8 $2.43 PSTV Short Interest - Frequently Asked Questions What is Plus Therapeutics' current short interest? Short interest is the volume of Plus Therapeutics shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 5,740,000 shares of PSTV short. 11.70% of Plus Therapeutics' shares are currently sold short. Learn More on Plus Therapeutics' current short interest. What is a good short interest percentage for Plus Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.70% of Plus Therapeutics' floating shares are currently sold short. Is Plus Therapeutics' short interest increasing or decreasing? Plus Therapeutics saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 5,740,000 shares, an increase of 390.6% from the previous total of 1,170,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Plus Therapeutics' short interest compare to its competitors? 11.70% of Plus Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Plus Therapeutics: Hyperfine, Inc. (5.17%), Sensus Healthcare, Inc. (6.33%), Zynex Inc. (45.18%), Cytosorbents Corporation (2.55%), Spectral AI, Inc. (4.90%), Vicarious Surgical Inc. (3.13%), IceCure Medical Ltd. (0.84%), SurgePays, Inc. (2.01%), EDAP TMS S.A. (0.16%), electroCore, Inc. (7.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Plus Therapeutics stock? Short selling PSTV is an investing strategy that aims to generate trading profit from Plus Therapeutics as its price is falling. PSTV shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Plus Therapeutics? A short squeeze for Plus Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PSTV, which in turn drives the price of the stock up even further. How often is Plus Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PSTV, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies Hyperfine Short Squeeze Sensus Healthcare Short Squeeze Zynex Short Squeeze Cytosorbents Short Squeeze Spectral AI Short Squeeze Vicarious Surgical Short Squeeze IceCure Medical Short Squeeze SurgePays Short Squeeze EDAP TMS Short Squeeze electroCore Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PSTV) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredTrump’s Endgame? (R.I.P. China)Tucked inside a Silicon Valley factory, a bold new tech is quietly emerging—one that could ignite a $12 trilli...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Plus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Plus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PSTV Stock Alerts